Anti-mGluR5 Antibody, clone 1F11 ZooMAb® Rabbit Monoclonal

Description

• General description: We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
• Specificity: Clone 1F11 is a ZooMAb® rabbit recombinant monoclonal antibody that specifically detects Metabotropic glutamate receptor 5 (mGluR5). It targets an epitope within 23 amino acids from the C-terminal region.
• Immunogen: KLH-conjugated linear peptide corresponding to 23 amino acids the C-terminal region of human Metabotropic glutamate receptor 5 (mGluR5).
• Application: Quality Control Testing Evaluated by Western Blotting in Rat brain microsome.Western Blotting Analysis: A 1:10,000 dilution of this antibody detected mGluR5 in Rat brain microsome. Tested applicationsAffinity Binding Assay: A representative lot of this antibody bound mGluR5 peptide with a KD of 2.0 x 10-8 in an affinity binding assay.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected mGluR5 in E18 rat cortical cells.Immunohistochemistry (Paraffin) Analysis: A 1:1,000 dilution from a representative lot detected mGluR5 in rat brain tissue sections.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
• Target description: Metabotropic glutamate receptor 5 (UniProt: P41594; also known as mGluR5) is encoded by the GRM5 (also known as GPRC1E, MGLUR5) gene (Gene ID: 2915) in human. Glutamate receptors can be grouped into ionotropic receptors and metabotropic receptors. Excitotoxic effects of glutamate analogs are primarily achieved through the activation of the ionotropic receptors. Glutamate can also activate metabotropic receptors that couple GTP-binding proteins to intracellular second messengers. These receptors are distributed throughout the central nervous system and are located at synaptic as well as extra-synaptic sites in neurons and glia. Metabotropic receptors contain a large extracellular N-terminal domain known as the Venus flytrap domain (VFD) that contains the glutamate-binding site and has two lobes that sit one atop the other and bind glutamate in a cleft between the two lobes. The VFD dimer can exist in open-open, open-closed, or in closed-closed state. The open-open state is an inactive conformation and is stabilized by antagonists. At least eight metabotropic glutamate receptors (mGluR1-8) have been reported. They are classified into three groups based on their sequence homology, agonist pharmacology, and coupling to intracellular transduction mechanisms. The mGluR1 and mGluR5 belong to group I and these receptors are coupled to post-synaptic inositol phosphate metabolism. They couple to Gq/G11 and activate phospholipase Cβ that hydrolyzes phosphoinositides to generate inositol 1, 4, 5-trisphosphate (IP3) and diacyl- glycerol (DAG), both of which participate in the activation of protein kinase C. Activation of Group I receptors leads to depolarization and increases neuronal excitability. mGluR1 is present at high levels in the cerebellum and thalamus and mGluR5 is found in superficial cortical layers and the olfactory bulb. The activation of mGluR1 generates a single spike in Ca2+ concentrations, whereas mGluR5 activation leads to Ca2+ oscillations via phosphorylation/dephosphorylation cycles. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals.
• Physical form: Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
• Reconstitution: 300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
• Storage and Stability: Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
• Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.